切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2018, Vol. 12 ›› Issue (08) : 427 -431. doi: 10.3877/cma.j.issn.1674-0785.2018.08.001

所属专题: 文献

述评

医疗大数据在临床医学中的应用现状
姜晓峰1,()   
  1. 1. 150001 哈尔滨医科大学附属第四临床医学院检验科
  • 收稿日期:2018-03-31 出版日期:2018-04-15
  • 通信作者: 姜晓峰

Application status of big data in clinical medicine

Xiaofeng Jiang1()   

  • Received:2018-03-31 Published:2018-04-15
  • Corresponding author: Xiaofeng Jiang
引用本文:

姜晓峰. 医疗大数据在临床医学中的应用现状[J]. 中华临床医师杂志(电子版), 2018, 12(08): 427-431.

Xiaofeng Jiang. Application status of big data in clinical medicine[J]. Chinese Journal of Clinicians(Electronic Edition), 2018, 12(08): 427-431.

1
Berger ML, Doban V. Big data, advanced analytics and the future of comparative effectiveness research [J]. J Comp Eff Res, 2014, 3(2):167-176.
2
Taylor RC. An overview of the Hadoop/MapReduce/HBase framework and its current applications in bioinformatics [J]. BMC Bioinformatics, 2010, 11 Suppl 12:S1.
3
Pandey RV, Schlötterer C. DistMap: a toolkit for distributed short read mapping on a Hadoop cluster [J]. PLoS One, 2013, 8(8):e72614.
4
Pennisi E. The biology of genomes. Single-cell sequencing tackles basic and biomedical questions [J]. Science, 2012, 336(6084):976-977.
5
Dolley S. Big data's role in precision public health[J]. Front Public Health, 2018, 6:68.
6
Hoeppner MA. NCBI Bookshelf: books and documents in life sciences and health care [J]. Nucleic Acids Res, 2013. 41(Database issue):D1251-1260.
7
Kolesnikov N, Hastings E, Keays M, et al. ArrayExpress update-simplifying data submissions [J]. Nucleic Acids Res, 2015, 43(Database issue):D1113-1116.
8
Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets-update[J]. Nucleic Acids Res, 2013, 41(Database issue):D991-995.
9
Keshava Prasad TS, Goel R, Kandasamy K,et al. Human Protein Reference Database-2009 update [J]. Nucleic Acids Res, 2009, 37(Database issue):D767-772.
10
Gene Ontology Consortium. Gene Ontology Consortium: going forward [J]. Nucleic Acids Res, 2015, 43(Database issue):D1049-1056.
11
Khatri P, Sirota M, Butte AJ.Ten years of pathway analysis: current approaches and outstanding challenges [J]. PLoS Comput Biol, 2012, 8(2):e1002375.
12
Wang K, Gaitsch H, Poon H,et al. Classification of common human diseases derived from shared genetic and environmental determinants [J]. Nat Genet, 2017, 49(9):1319-1325.
13
Escott-Price V, Bellenguez C, Wang LS, et al. Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease [J]. PLoS One, 2014, 9(6):e94661.
14
Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration [J]. Science, 2005, 308(5720):385-389.
15
Li L, Cheng WY, Glicksberg BS, et al. Identification of type 2 diabetes subgroups through topological analysis of patient similarity [J]. Sci Transl Med, 2015, 7(311):311ra174.
16
Esteva A, Kuprel B, Novoa RA, et al. Dermatologist-level classification of skin cancer with deep neural networks [J]. Nature, 2017, 542(7639):115-118.
17
Lorberbaum T, Sampson KJ, Woosley RL, et al. An integrative data science pipeline to identify novel drug interactions that prolong the QT interval [J]. Drug Saf, 2016, 39(5):433-441.
18
Singer M, Wang C, Cong L, et al. A distinct gene module for dysfunction uncoupled from activation in tumor-infiltrating T cells [J].Cell, 2016, 166(6):1500-1511. e9.
19
Chandran UR, Ma C, Dhir R, et al. Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process [J]. BMC Cancer, 2007,7:64.
20
Hou Y, Lautrup S, Cordonnier S, et al. NAD supplementation normalizes key Alzheimer′s features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency [J]. Proc Natl Acad Sci U S A, 2018, 115(8):E1876-E1885.
21
Altman MC, Whalen E, Togias A, et al. Allergen-induced activation of natural killer cells represents an early-life immune response in the development of allergic asthma [J]. J Allergy Clin Immunol, Epub 2018 Mar 5.
22
Hinshaw SM, Makrantoni V, Harrison SC, et al.The Kinetochore receptor for the cohesin loading complex [J]. Cell, 2017, 171(1):72-84. e13.
23
Minear MA, Lewis C, Pradhan S, et al.Global perspectives on clinical adoption of NIPT [J]. Prenat Diagn, 2015, 35(10):959-967.
24
Iorio F, Knijnenburg TA, Vis DJ, et al.A landscape of pharmacogenomic interactions in cancer [J]. Cell, 2016, 166(3):740-754.
25
von Eichborn J, Murgueitio MS, Dunkel M, et al.PROMISCUOUS: a database for network-based drug-repositioning [J]. Nucleic Acids Res, 2011, 39(Database issue):D1060-1066.
26
Keiser MJ, Setola V, Irwin JJ, et al.Predicting new molecular targets for known drugs [J]. Nature, 2009, 462(7270):175-181.
27
Guinney J, Dienstmann R, Wang X, et al.The consensus molecular subtypes of colorectal cancer [J]. Nat Med, 2015, 21(11):1350-1356.
28
Delude CM. Deep phenotyping: the details of disease [J]. Nature, 2015, 527(7576):S14-15.
29
Liu X, Zhang Y, Chen Y, et al.In situ capture of chromatin interactions by biotinylated dCas9 [J]. Cell, 2017, 170(5):1028-1043.e19.
30
Plaisier CL, O′Brien S, Bernard B, et al. Causal mechanistic regulatory network for glioblastoma deciphered using systems genetics network analysis [J]. Cell Syst, 2016, 3(2):172-186.
31
Bailey P, Chang DK, Nones K, et al.Genomic analyses identify molecular subtypes of pancreatic cancer [J]. Nature, 2016, 531(7592):47-52.
32
Altaf-Ul-Amin M, Afendi FM, Kiboi SK, et al.Systems biology in the context of big data and networks [J]. Biomed Res Int, 2014, 2014:428570.
33
Flores M, Glusman G, Brogaard K, et al.P4 medicine: how systems medicine will transform the healthcare sector and society [J]. Per Med, 2013, 10(6):565-576.
34
Stuart JM, Segal E, Koller D, et al.A gene-coexpression network for global discovery of conserved genetic modules [J]. Science, 2003, 302(5643):249-255.
35
Zhang B, Horvath S.A general framework for weighted gene co-expression network analysis [J]. Stat Appl Genet Mol Biol, 2005, 4:Article17.
36
Langfelder P, Horvath S.WGCNA: an R package for weighted correlation network analysis [J]. BMC Bioinformatics, 2008, 9:559.
37
Dalerba P, Sahoo D, Paik S,et al.CDX2 as a prognostic biomarker in stage Ⅱ and stage Ⅲ colon cancer [J]. N Engl J Med, 2016, 374(3):211-222.
38
Yan H, Guan Q, He J, et al. Individualized analysis reveals CpG sites with methylation aberrations in almost all lung adenocarcinoma tissues [J]. J Transl Med, 2017, 15(1):26.
39
Ziegler A, Koch A, Krockenberger K, et al. Personalized medicine using DNA biomarkers: a review [J]. Hum Genet, 2012, 131(10):1627-1638.
40
Hartwell L, Mankoff D, Paulovich A, et al.Cancer biomarkers: a systems approach [J]. Nat Biotechnol, 2006, 24(8):905-908.
41
King LY, Canasto-Chibuque C, Johnson KB, et al.A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration [J]. Gut, 2015, 64(8):1296-1302.
42
Mehrmann L, Ollenschläger G. Problem areas and examples of best practice in intersectoral medication treatment-a literature review [J]. Z Evid Fortbild Qual Gesundhwes, 2014, 108(1):66-77.
43
Nelson AM. Best practice in nursing: a concept analysis [J]. Int J Nurs Stud, 2014, 51(11):1507-1516.
44
Porter NR, Eberth JM, Samson ME, et al. Diabetes status and being up-to-date on colorectal cancer screening, 2012 behavioral risk factor surveillance system [J]. Prev Chronic Dis, 2016, 13:E19.
No related articles found!
阅读次数
全文


摘要